DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @AmericanBanking | 4 |
| @dailypoliticaln | 4 |
| @ZolmaxNews | 3 |
| @WatchlistN | 2 |
| @EnterpriseLeade | 2 |
Recent Tweets for ALKS
 |
@TickerReport Alkermes $ALKS Receives Buy Rating from Cowen https://t.co/qT9JyyHnhj 2:09am |
 |
@ZolmaxNews Alkermes $ALKS Upgraded at BidaskClub https://t.co/laDwauhonh September 15th 2019, 1:09am |
 |
@dailypoliticaln Alkermes $ALKS Upgraded at BidaskClub https://t.co/RwYykf4jpW September 15th 2019, 1:09am |
 |
@ConsumerFeed Alkermes’ $ALKS “Buy” Rating Reaffirmed at Cowen https://t.co/NsA3vicaDd September 14th 2019, 3:09pm |
 |
@EnterpriseLeade Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/C2h8gDrjBQ September 14th 2019, 2:09pm |
 |
@registrarjourn Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/GDBrGX203P September 14th 2019, 2:09pm |
 |
@dispatchtribune Insider Selling: Alkermes Plc $ALKS CEO Sells 100,000 Shares of Stock https://t.co/ugXE0wWSit September 14th 2019, 2:09pm |
 |
@OlympiaReport Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/grTTZw5smX September 14th 2019, 2:09pm |
 |
@WatchlistN Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.39 EPS https://t.co/munrBxIPU5 September 14th 2019, 1:09pm |
|
@ZolmaxNews Alkermes Plc $ALKS Expected to Post Quarterly Sales of $250.98 Million https://t.co/wuXlixCBKP September 14th 2019, 1:09pm |
|
@dailypoliticaln Alkermes Plc $ALKS Expected to Announce Earnings of -$0.39 Per Share https://t.co/qM2eXbgrku September 14th 2019, 1:09pm |
|
@TickerReport Alkermes $ALKS Raised to “Hold” at BidaskClub https://t.co/R1VkrnTKSj September 14th 2019, 7:09am |
 |
@1MinuteStock We calculated 63-day Expected Return of $ALKS for you: 4.39% https://t.co/QC07r3PdnH September 13th 2019, 9:09pm |
 |
@AmericanBanking Alkermes Plc $ALKS CEO Sells $2,268,000.00 in Stock https://t.co/rIZLw5fBr1 #stocks September 13th 2019, 6:09pm |
|
@ZolmaxNews Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares https://t.co/uRJ0owK2p6 September 13th 2019, 6:09pm |
|
@dailypoliticaln Alkermes Plc $ALKS CEO Sells $2,268,000.00 in Stock https://t.co/cfXmH5RKvH September 13th 2019, 6:09pm |
 |
@InsiderAlertsIA $ALKS: New Insider Filing on Director and CEO, Alkermes plc RICHARD F POPS: https://t.co/R8pE0beosY September 13th 2019, 5:09pm |
 |
@Briefingcom $ALKS: Alkermes founder Floyd Bloom, M.D. retires from Board https://t.co/EvbUVYvl7m September 13th 2019, 9:09am |
 |
@Stock_News_Now $ALKS: New SEC Filing for ALKS: Form 8-K (No. 0001564590-19-034637): https://t.co/wNHFjab1Yp September 13th 2019, 8:09am |
|
@AmericanBanking Alkermes’ $ALKS “Buy” Rating Reaffirmed at Cowen https://t.co/bfF7MoIaub #stocks September 13th 2019, 8:09am |
 |
@StockTexts $ALKS Alkermes plc SEC Filing: Form 8-K https://t.co/FimXrwS6T7 September 13th 2019, 7:09am |
 |
@confcalltran Alkermes Announces The Appointment Of Richard Gaynor, M.D. And Andy Wilson To Its Board Of Dire https://t.co/JtnTaedObI $ALKS September 13th 2019, 7:09am |
 |
@ProVesting $ALKS: Alkermes Announces the Appointment of Richard Gaynor, MD and …: https://t.co/tr18yGxRYr September 13th 2019, 7:09am |
 |
@stocknewstimes Zacks: Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.20 Earnings Per Share https://t.co/YIgjqsZKq6 September 12th 2019, 5:09pm |
 |
@macondailynews Zacks: Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.20 Earnings Per Share https://t.co/9TZ7KYYFXM September 12th 2019, 5:09pm |
 |
@TheMarketsDaily Alkermes Plc $ALKS Expected to Announce Earnings of -$0.20 Per Share https://t.co/IXGqQBjs6b September 12th 2019, 5:09pm |
|
@AmericanBanking $250.98 Million in Sales Expected for Alkermes Plc $ALKS This Quarter https://t.co/FVIU0NVlBI #stocks September 11th 2019, 5:09am |
|
@dispatchtribune Alkermes $ALKS Shares Up 6.8% https://t.co/Bop4yhK1lt September 10th 2019, 11:09pm |
|
@OlympiaReport Alkermes $ALKS Shares Up 6.8% https://t.co/UanOt8oZW7 September 10th 2019, 11:09pm |
|
@registrarjourn Alkermes $ALKS Shares Up 6.8% https://t.co/XnYFVcUlK8 September 10th 2019, 11:09pm |
|
@EnterpriseLeade Alkermes $ALKS Shares Up 6.8% https://t.co/N7PW5veGmH September 10th 2019, 11:09pm |
 |
@SeekingAlpha $ALKS - Alkermes (ALKS) Investor Presentation - Slideshow https://t.co/zzc4wK1O3f September 10th 2019, 3:09pm |
|
@AmericanBanking Brokerages Expect Alkermes Plc $ALKS Will Announce Earnings of -$0.20 Per Share https://t.co/urADBxXnJ3 #stocks September 9th 2019, 2:09am |
 |
@WeekHerald Alkermes Plc $ALKS Receives $31.70 Average Price Target from Analysts https://t.co/zkeEeOSCvT September 9th 2019, 12:09am |
 |
@ThisLincolnian Alkermes Plc $ALKS Given Average Rating of “Hold” by Analysts https://t.co/rAardkt4rQ September 9th 2019, 12:09am |
|
@stocknewstimes Alkermes $ALKS Raised to “Equal” at Morgan Stanley https://t.co/SYe3SZmk5N September 8th 2019, 9:09am |
 |
@TranscriptDaily Alkermes $ALKS Raised to “Equal” at Morgan Stanley https://t.co/16PQN2jHKH September 8th 2019, 9:09am |
|
@dailypoliticaln Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/tOAOhGHJL3 September 7th 2019, 1:09pm |
|
@WatchlistN Insider Selling: Alkermes Plc $ALKS CEO Sells 100,000 Shares of Stock https://t.co/5mLHly6Tw1 September 7th 2019, 1:09pm |
|
@1MinuteStock Wondering about risks of $ALKS? The 63-day volatility is 22.22% https://t.co/cQn3ldIe1K August 11th 2019, 5:08am |
|
@ZolmaxNews Alkermes $ALKS Shares Up 5.3% https://t.co/bCRBFC2LZC August 10th 2019, 5:08pm |
|
@OlympiaReport Analysts Set Alkermes Plc $ALKS Price Target at $31.70 https://t.co/gtPMsuBtuW August 10th 2019, 5:08pm |
|
@ThisLincolnian Analysts Set Alkermes Plc $ALKS Price Target at $31.70 https://t.co/cYURmfqVWW August 10th 2019, 5:08pm |
|
@WeekHerald Alkermes Plc $ALKS Receives $31.70 Consensus Price Target from Brokerages https://t.co/0jjd1Pf2oi August 10th 2019, 5:08pm |
 |
@bbnsnews Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/BL1zrZcRl1 August 8th 2019, 2:08pm |
|
@AmericanBanking Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/2upCOZIEZt #stocks August 8th 2019, 2:08pm |
|
@ThisLincolnian Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/IDKTL63qdt August 8th 2019, 2:08pm |
|
@AmericanBanking Alkermes Plc $ALKS Receives Average Rating of “Hold” from Brokerages https://t.co/cgJGPjrN6T #stocks August 7th 2019, 10:08am |
|
@ConsumerFeed Alkermes Plc $ALKS Receives Average Rating of “Hold” from Brokerages https://t.co/vj6hBpm9TH August 7th 2019, 10:08am |
 |
@fda_tracker $ALKS Phase 3 trial w/est Aug completion date NCT02873208: https://t.co/kfFuXWDuJ7 Trial Tracker: https://t.co/aR7q5oJwjn August 6th 2019, 9:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.